{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:38Z","timestamp":1793374238216,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"crossref","award":["1S19725N"],"award-info":[{"award-number":["1S19725N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"crossref","award":["1226224N"],"award-info":[{"award-number":["1226224N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13346-025-01987-6","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:41:50Z","timestamp":1760985710000},"page":"1860-1876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strategic lipid nanoparticle design dictates retinal delivery post inner limiting membrane disruption"],"prefix":"10.1007","volume":"16","author":[{"given":"Kaat","family":"De Clerck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"De Coster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-4938","authenticated-orcid":false,"given":"Karen","family":"Peynshaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"1987_CR1","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/SCIENCE.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465\u20138. https:\/\/doi.org\/10.1126\/SCIENCE.1690918.","journal-title":"Science"},{"key":"1987_CR2","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7\/ATTACHMENT\/2F234B8F-9B08-44A7-A6AE-222FBE603901\/MMC1.PDF","volume":"9","author":"RRA Bourne","year":"2021","unstructured":"Bourne RRA, Steinmetz JD, Saylan M, Mersha AM, Weldemariam AH, Wondmeneh TG, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9:e144\u201360. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7\/ATTACHMENT\/2F234B8F-9B08-44A7-A6AE-222FBE603901\/MMC1.PDF.","journal-title":"Lancet Glob Health"},{"key":"1987_CR3","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","volume":"9","author":"RRA Bourne","year":"2021","unstructured":"Bourne RRA, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9:e130\u201343. https:\/\/doi.org\/10.1016\/S2214-109X(20)30425-3.","journal-title":"Lancet Glob Health"},{"key":"1987_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/NBT0118-6A","volume":"36","author":"FDA approves hereditary blindness gene therapy","year":"2018","unstructured":"FDA approves hereditary blindness gene therapy. Nat Biotechnol. 2018;36:6. https:\/\/doi.org\/10.1038\/NBT0118-6A.","journal-title":"Nat Biotechnol"},{"issue":"7836","key":"1987_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-020-2975-4","volume":"588","author":"Y Lu","year":"2020","unstructured":"Lu Y, Brommer B, Tian X, Krishnan A, Meer M, Wang C, et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020;588(7836):124\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2975-4.","journal-title":"Nature"},{"key":"1987_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.ABQ7219","author":"L Todd","year":"2022","unstructured":"Todd L, Jenkins W, Finkbeiner C, Hooper MJ, Donaldson PC, Pavlou M, et al. Reprogramming M\u00fcller glia to regenerate ganglion-like cells in adult mouse retina with developmental transcription factors. Sci Adv. 2022. https:\/\/doi.org\/10.1126\/SCIADV.ABQ7219.","journal-title":"Sci Adv"},{"key":"1987_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELREP.2021.109857","author":"L Todd","year":"2021","unstructured":"Todd L, Hooper MJ, Haugan AK, Finkbeiner C, Jorstad N, Radulovich N, et al. Efficient stimulation of retinal regeneration from M\u00fcller glia in adult mice using combinations of proneural bHLH transcription factors. Cell Rep. 2021. https:\/\/doi.org\/10.1016\/J.CELREP.2021.109857.","journal-title":"Cell Rep"},{"key":"1987_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/J.DRUDIS.2019.01.023","volume":"24","author":"J Devoldere","year":"2019","unstructured":"Devoldere J, Peynshaert K, De Smedt SC, Remaut K. M\u00fcller cells as a target for retinal therapy. Drug Discov Today. 2019;24:1483\u201398. https:\/\/doi.org\/10.1016\/J.DRUDIS.2019.01.023.","journal-title":"Drug Discov Today"},{"key":"1987_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-018-1041-8","author":"A Osborne","year":"2018","unstructured":"Osborne A, Khatib TZ, Songra L, Barber AC, Hall K, Kong GYX, et al. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling. Cell Death Dis. 2018. https:\/\/doi.org\/10.1038\/S41419-018-1041-8.","journal-title":"Cell Death Dis"},{"issue":"8","key":"1987_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/s12276-023-01057-2","volume":"55","author":"EH Choi","year":"2023","unstructured":"Choi EH, Suh S, Sears AE, Ho\u0142ubowicz R, Kedhar SR, Browne AW, et al. Genome editing in the treatment of ocular diseases. Exp Mol Med. 2023;55(8):1678\u201390. https:\/\/doi.org\/10.1038\/s12276-023-01057-2.","journal-title":"Exp Mol Med"},{"key":"1987_CR11","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/PHARMACEUTICS14081716","volume":"14","author":"K De Clerck","year":"2022","unstructured":"De Clerck K, Accou G, Sauvage F, Braeckmans K, De Smedt SC, Remaut K, et al. Photodisruption of the inner limiting membrane: exploring ICG loaded nanoparticles as photosensitizers. Pharmaceutics. 2022;14:1716. https:\/\/doi.org\/10.3390\/PHARMACEUTICS14081716.","journal-title":"Pharmaceutics"},{"key":"1987_CR12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","volume":"328","author":"S Tavakoli","year":"2020","unstructured":"Tavakoli S, Peynshaert K, Lajunen T, Devoldere J, del Amo EM, Ruponen M, et al. Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface. J Control Release. 2020;328:952\u201361. https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.028.","journal-title":"J Control Release"},{"key":"1987_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/J.JCONREL.2022.07.002","volume":"349","author":"K Peynshaert","year":"2022","unstructured":"Peynshaert K, Vanluchene H, De Clerck K, Minnaert A-K, Verhoeven M, Gouspillou N, et al. Icg-mediated photodisruption of the inner limiting membrane enhances retinal drug delivery. J Control Release. 2022;349:315\u201326. https:\/\/doi.org\/10.1016\/J.JCONREL.2022.07.002.","journal-title":"J Control Release"},{"key":"1987_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/J.EJPB.2019.05.023","volume":"141","author":"J Devoldere","year":"2019","unstructured":"Devoldere J, Wels M, Peynshaert K, Dewitte H, De Smedt SC, Remaut K. The obstacle course to the inner retina: hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane. Eur J Pharm Biopharm. 2019;141:161\u201371. https:\/\/doi.org\/10.1016\/J.EJPB.2019.05.023.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1987_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/17425247.2023.2167979","volume":"20","author":"K Peynshaert","year":"2023","unstructured":"Peynshaert K, Devoldere J, De Smedt S, Remaut K. Every nano-step counts: a critical reflection on do\u2019s and don\u2019ts in researching nanomedicines for retinal gene therapy. Expert Opin Drug Deliv. 2023;20(2):259\u201371. https:\/\/doi.org\/10.1080\/17425247.2023.2167979.","journal-title":"Expert Opin Drug Deliv"},{"key":"1987_CR16","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/MT.2009.181","volume":"17","author":"D Dalkara","year":"2009","unstructured":"Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, Schaffer DV, et al. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther. 2009;17:2096. https:\/\/doi.org\/10.1038\/MT.2009.181.","journal-title":"Mol Ther"},{"key":"1987_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/J.JCONREL.2019.06.042","volume":"307","author":"J Devoldere","year":"2019","unstructured":"Devoldere J, Peynshaert K, Dewitte H, Vanhove C, De Groef L, Moons L, et al. Non-viral delivery of chemically modified mRNA to the retina: subretinal versus intravitreal administration. J Control Release. 2019;307:315\u201330. https:\/\/doi.org\/10.1016\/J.JCONREL.2019.06.042.","journal-title":"J Control Release"},{"key":"1987_CR18","doi-asserted-by":"publisher","first-page":"e0241006","DOI":"10.1371\/JOURNAL.PONE.0241006","volume":"15","author":"RC Ryals","year":"2020","unstructured":"Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of PEGylation on LNP based mRNA delivery to the eye. PLoS ONE. 2020;15:e0241006. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0241006.","journal-title":"PLoS ONE"},{"key":"1987_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.ADD4623","author":"M Herrera-Barrera","year":"2023","unstructured":"Herrera-Barrera M, Ryals RC, Gautam M, Jozic A, Landry M, Korzun T, et al. Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Sci Adv. 2023. https:\/\/doi.org\/10.1126\/SCIADV.ADD4623.","journal-title":"Sci Adv"},{"key":"1987_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114027","author":"W Li","year":"2025","unstructured":"Li W, Vanluchene H, Raes L, Peynshaert K, Veys L, Hern\u00e1ndez SG, et al. Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye. J Control Release. 2025. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114027.","journal-title":"J Control Release"},{"issue":"1","key":"1987_CR21","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1080\/10717544.2017.1375578","volume":"24","author":"K Peynshaert","year":"2017","unstructured":"Peynshaert K, Devoldere J, Forster V, Picaud S, Vanhove C, De Smedt SC, et al. Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface. Drug Deliv. 2017;24(1):1384\u201394. https:\/\/doi.org\/10.1080\/10717544.2017.1375578.","journal-title":"Drug Deliv"},{"key":"1987_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/S13346-025-01921-W","author":"L Paoletti","year":"2025","unstructured":"Paoletti L, De Clerck K, De Coster E, Matricardi P, Remaut K, Peynshaert K. Advancing nanoparticle delivery studies: flow cytometry-based quantification of nanoparticle uptake and transfection in retinal tissue. Drug Deliv Transl Res. 2025. https:\/\/doi.org\/10.1007\/S13346-025-01921-W.","journal-title":"Drug Deliv Transl Res"},{"key":"1987_CR23","unstructured":"CHMP, Spikevax, INN-elasomeran, elasomeran\/imelasomeran, elasomeran\/davesomeran, andusomeran, COVID-19 mRNA Vaccine, (n.d.)."},{"key":"1987_CR24","unstructured":"CHMP, Comirnaty, INN-raxtozinameran, bretovameran, mRNA encoding KP.2, (n.d.)."},{"key":"1987_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.JCONREL.2023.03.039","volume":"357","author":"S Meulewaeter","year":"2023","unstructured":"Meulewaeter S, Nuytten G, Cheng MHY, De Smedt SC, Cullis PR, De Beer T, et al. Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures. J Control Release. 2023;357:149\u201360. https:\/\/doi.org\/10.1016\/J.JCONREL.2023.03.039.","journal-title":"J Control Release"},{"key":"1987_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","volume":"44","author":"K Peynshaert","year":"2019","unstructured":"Peynshaert K, Devoldere J, Minnaert AK, De Smedt SC, Remaut K. Morphology and composition of the inner limiting membrane: species-specific variations and relevance toward drug delivery research. Curr Eye Res. 2019;44:465\u201375. https:\/\/doi.org\/10.1080\/02713683.2019.1565890.","journal-title":"Curr Eye Res"},{"key":"1987_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1167\/IOVS.09-3884","volume":"51","author":"TV Johnson","year":"2010","unstructured":"Johnson TV, Bull ND, Martin KR. Identification of barriers to retinal engraftment of transplanted stem cells. Invest Ophthalmol Vis Sci. 2010;51:960. https:\/\/doi.org\/10.1167\/IOVS.09-3884.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1987_CR28","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100811","author":"SW Lukowski","year":"2019","unstructured":"Lukowski SW, Lo CY, Sharov AA, Nguyen Q, Fang L, Hung SS, et al. A single-cell transcriptome atlas of the adult human retina. EMBO J. 2019. https:\/\/doi.org\/10.15252\/embj.2018100811.","journal-title":"EMBO J"},{"key":"1987_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.STEMCR.2020.12.001","volume":"16","author":"KY Zhang","year":"2021","unstructured":"Zhang KY, Tuffy C, Mertz JL, Quillen S, Wechsler L, Quigley HA, et al. Role of the internal limiting membrane in structural engraftment and topographic spacing of transplanted human stem cell-derived retinal ganglion cells. Stem Cell Reports. 2021;16:149\u201367. https:\/\/doi.org\/10.1016\/J.STEMCR.2020.12.001.","journal-title":"Stem Cell Reports"},{"key":"1987_CR30","doi-asserted-by":"publisher","unstructured":"E. De Coster, K. De Clerck, C. De Clercq, W. Li, D. Punj, B. Vanmeerhaeghe, S. De Smedt, K. Braeckmans, H. Hadady, K. Remaut, T.V. Johnson, K. Peynshaert, Photodisruption of the inner limiting membrane promotes retinal engraftment of stem-cell derived retinal ganglion cells, BioRxiv (2025) 2025.04.14.648093. https:\/\/doi.org\/10.1101\/2025.04.14.648093.","DOI":"10.1101\/2025.04.14.648093"},{"key":"1987_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41578-021-00358-0","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mrna delivery. Nat Rev Mater. 2021. https:\/\/doi.org\/10.1038\/s41578-021-00358-0.","journal-title":"Nat Rev Mater"},{"key":"1987_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/ACS.ACCOUNTS.1C00544\/ASSET\/IMAGES\/LARGE\/AR1C00544_0005.JPEG","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris Y, Gupta M, Kim J, Sahay G. Chemistry of lipid nanoparticles for RNA delivery. Acc Chem Res. 2022;55:2\u201312. https:\/\/doi.org\/10.1021\/ACS.ACCOUNTS.1C00544\/ASSET\/IMAGES\/LARGE\/AR1C00544_0005.JPEG.","journal-title":"Acc Chem Res"},{"key":"1987_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ADHM.202203022","volume":"12","author":"KN Kafetzis","year":"2023","unstructured":"Kafetzis KN, Papalamprou N, McNulty E, Thong KX, Sato Y, Mironov A, et al. The effect of cryoprotectants and storage conditions on the transfection efficiency, stability, and safety of lipid-based nanoparticles for mRNA and DNA delivery. Adv Healthc Mater. 2023;12:2203022. https:\/\/doi.org\/10.1002\/ADHM.202203022.","journal-title":"Adv Healthc Mater"},{"key":"1987_CR34","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/D0BM01609H","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang R, El-Mayta R, Murdoch TJ, Warzecha CC, Billingsley MM, Shepherd SJ, et al. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to Spleen and Liver. Biomater Sci. 2021;9:1449. https:\/\/doi.org\/10.1039\/D0BM01609H.","journal-title":"Biomater Sci"},{"key":"1987_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/S41596-022-00755-X","author":"X Wang","year":"2022","unstructured":"Wang X, Liu S, Sun Y, Yu X, Lee SM, Cheng Q, et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat Protoc. 2022. https:\/\/doi.org\/10.1038\/S41596-022-00755-X.","journal-title":"Nat Protoc"},{"key":"1987_CR36","doi-asserted-by":"publisher","first-page":"114990","DOI":"10.1016\/J.ADDR.2023.114990","volume":"200","author":"M Jeong","year":"2023","unstructured":"Jeong M, Lee Y, Park J, Jung H, Lee H. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications. Adv Drug Deliv Rev. 2023;200:114990. https:\/\/doi.org\/10.1016\/J.ADDR.2023.114990.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1987_CR37","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han X, Zhang H, Butowska K, Swingle KL, Alameh MG, Weissman D, et al. An ionizable lipid toolbox for RNA delivery. Nature Commun. 2021;12(1):7233. https:\/\/doi.org\/10.1038\/s41467-021-27493-0.","journal-title":"Nature Commun"},{"key":"1987_CR38","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/J.ADDR.2022.114416","volume":"188","author":"CH Albertsen","year":"2022","unstructured":"Albertsen CH, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416. https:\/\/doi.org\/10.1016\/J.ADDR.2022.114416.","journal-title":"Adv Drug Deliv Rev"},{"issue":"31","key":"1987_CR39","doi-asserted-by":"publisher","first-page":"2303370","DOI":"10.1002\/adma.202303370","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng MHY, Leung J, Zhang Y, Strong C, Basha G, Momeni A, et al. Induction of Bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv Mater. 2023;35(31):2303370.","journal-title":"Adv Mater"},{"key":"1987_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/J.JCONREL.2019.04.015","volume":"303","author":"S Patel","year":"2019","unstructured":"Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91. https:\/\/doi.org\/10.1016\/J.JCONREL.2019.04.015.","journal-title":"J Control Release"},{"issue":"1","key":"1987_CR41","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","volume":"14","author":"M Gautam","year":"2023","unstructured":"Gautam M, Jozic A, Su GL, Herrera-Barrera M, Curtis A, Arrizabalaga S, et al. Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nat Commun. 2023;14(1):6468. https:\/\/doi.org\/10.1038\/s41467-023-42189-3.","journal-title":"Nat Commun"},{"key":"1987_CR42","doi-asserted-by":"publisher","first-page":"2400815","DOI":"10.1002\/SMLL.202400815","volume":"20","author":"Y Eygeris","year":"2024","unstructured":"Eygeris Y, Henderson MI, Curtis AG, Jozi A, Stoddard J, Reynaga R, et al. Preformed vesicle approach to LNP manufacturing enhances retinal mRNA delivery. Small. 2024;20:2400815. https:\/\/doi.org\/10.1002\/SMLL.202400815.","journal-title":"Small"},{"key":"1987_CR43","doi-asserted-by":"publisher","first-page":"e2307813120","DOI":"10.1073\/PNAS.2307813120\/SUPPL_FILE\/PNAS.2307813120.SAPP.PDF","volume":"121","author":"Y Eygeris","year":"2024","unstructured":"Eygeris Y, Gupta M, Kim J, Jozic A, Gautam M, Renner J, et al. Thiophene-based lipids for mRNA delivery to pulmonary and retinal tissues. Proc Natl Acad Sci U S A. 2024;121:e2307813120. https:\/\/doi.org\/10.1073\/PNAS.2307813120\/SUPPL_FILE\/PNAS.2307813120.SAPP.PDF.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1987_CR44","doi-asserted-by":"publisher","DOI":"10.1167\/TVST.13.7.7","volume":"13","author":"CZ Chambers","year":"2024","unstructured":"Chambers CZ, Soo GL, Engel AL, Glass IA, Frassetto A, Martini PGV, et al. Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues. Transl Vis Sci Technol. 2024;13(7):7. https:\/\/doi.org\/10.1167\/TVST.13.7.7.","journal-title":"Transl Vis Sci Technol"},{"key":"1987_CR45","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/ACS.NANOLETT.5B02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman KJ, Dorkin JR, Yang JH, Heartlein MW, Derosa F, Mir FF, et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 2015;15:7300\u20136. https:\/\/doi.org\/10.1021\/ACS.NANOLETT.5B02497.","journal-title":"Nano Lett"},{"key":"1987_CR46","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.1039\/C9NR02004G","volume":"11","author":"JA Kulkarni","year":"2019","unstructured":"Kulkarni JA, Witzigmann D, Leung J, Van Der Meel R, Zaifman J, Darjuan MM, et al. Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads. Nanoscale. 2019;11:9023\u201331. https:\/\/doi.org\/10.1039\/C9NR02004G.","journal-title":"Nanoscale"},{"key":"1987_CR47","doi-asserted-by":"publisher","first-page":"604205","DOI":"10.3389\/FIMMU.2020.604205\/XML\/NLM","volume":"11","author":"W Kwon","year":"2020","unstructured":"Kwon W, Freeman SA. Phagocytosis by the retinal pigment epithelium: Recognition, resolution, recycling. Front Immunol. 2020;11:604205. https:\/\/doi.org\/10.3389\/FIMMU.2020.604205\/XML\/NLM.","journal-title":"Front Immunol"},{"key":"1987_CR48","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1038\/MTNA.2013.66","volume":"2","author":"BL Mui","year":"2013","unstructured":"Mui BL, Tam YK, Jayaraman M, Ansell SM, Du X, Tam YYC, et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol Ther Nucleic Acids. 2013;2:e139. https:\/\/doi.org\/10.1038\/MTNA.2013.66.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1987_CR49","doi-asserted-by":"publisher","first-page":"114266","DOI":"10.1016\/J.EJPB.2024.114266","volume":"198","author":"M Ongun","year":"2024","unstructured":"Ongun M, Lokras AG, Baghel S, Shi Z, Schmidt ST, Franzyk H, et al. Lipid nanoparticles for local delivery of mRNA to the respiratory tract: effect of PEG-lipid content and administration route. Eur J Pharm Biopharm. 2024;198:114266. https:\/\/doi.org\/10.1016\/J.EJPB.2024.114266.","journal-title":"Eur J Pharm Biopharm"},{"key":"1987_CR50","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/PHARMACEUTICS13122097\/S1","volume":"13","author":"H Tanaka","year":"2021","unstructured":"Tanaka H, Miyama R, Sakurai Y, Tamagawa S, Nakai Y, Tange K, et al. Improvement of mrna delivery efficiency to a t cell line by modulating peg-lipid content and phospholipid components of lipid nanoparticles. Pharmaceutics. 2021;13:2097. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13122097\/S1.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1987_CR51","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1038\/s41467-022-33157-4","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, Hu Y, Li A, Lin J, Hsieh K, Schneiderman Z, et al. Payload distribution and capacity of mRNA lipid nanoparticles. Nat Commun. 2022;13(1):5561. https:\/\/doi.org\/10.1038\/s41467-022-33157-4.","journal-title":"Nat Commun"},{"key":"1987_CR52","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.BIOCONJCHEM.3C00174","author":"R Tenchov","year":"2023","unstructured":"Tenchov R, Sasso JM, Zhou QA. Pegylated lipid nanoparticle formulations: immunological safety and efficiency perspective. Bioconjug Chem. 2023. https:\/\/doi.org\/10.1021\/ACS.BIOCONJCHEM.3C00174.","journal-title":"Bioconjug Chem"},{"key":"1987_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/J.ADDR.2020.07.024","volume":"154\u2013155","author":"GT Kozma","year":"2020","unstructured":"Kozma GT, Shimizu T, Ishida T, Szebeni J. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev. 2020;154\u2013155:163\u201375. https:\/\/doi.org\/10.1016\/J.ADDR.2020.07.024.","journal-title":"Adv Drug Deliv Rev"},{"key":"1987_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","volume":"57","author":"EM del Amo","year":"2017","unstructured":"del Amo EM, Rimpel\u00e4 AK, Heikkinen E, Kari OK, Ramsay E, Lajunen T, et al. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017;57:134\u201385. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.12.001.","journal-title":"Prog Retin Eye Res"},{"key":"1987_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.07.046","author":"JB Simonsen","year":"2024","unstructured":"Simonsen JB. A perspective on bleb and empty LNP structures. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.046.","journal-title":"J Control Release"},{"key":"1987_CR56","doi-asserted-by":"publisher","first-page":"108545","DOI":"10.1016\/j.exer.2021.108545","volume":"206","author":"KY Zhang","year":"2021","unstructured":"Zhang KY, Johnson TV. The internal limiting membrane: roles in retinal development and implications for emerging ocular therapies. Exp Eye Res. 2021;206:108545. https:\/\/doi.org\/10.1016\/j.exer.2021.108545.","journal-title":"Exp Eye Res"},{"key":"1987_CR57","doi-asserted-by":"publisher","unstructured":"E.A. Aguzzi, B. Bonakdar, M. Mowlavi Vardanjani, E. Kimball, S. Mary, K.Y. Zhang, J. Du, A. Nagalingam, S. Quillen, S. Hariharakumar, H.A. Quigley, D.J. Zack, J.T. Handa, T. V Johnson, C. Author, T. Shelley, A. Holt rising professor of ophthalmology, internal limiting basement membrane inhibits functional engraftment of transplanted human retinal ganglion cells, BioRxiv (2025) 2022.12.13.519327. https:\/\/doi.org\/10.1101\/2022.12.13.519327.","DOI":"10.1101\/2022.12.13.519327"},{"key":"1987_CR58","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/J.OMTM.2017.12.002","volume":"9","author":"J Cehajic-Kapetanovic","year":"2018","unstructured":"Cehajic-Kapetanovic J, Milosavljevic N, Bedford RA, Lucas RJ, Bishop PN. Efficacy and safety of glycosidic enzymes for improved gene delivery to the retina following intravitreal injection in mice. Mol Ther Methods Clin Dev. 2018;9:192. https:\/\/doi.org\/10.1016\/J.OMTM.2017.12.002.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1987_CR59","unstructured":"J. Cehajic-Kapetanovic, M.M. Le Goff, A. Allen, R.J. Lucas, P.N. Bishop, Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2, (2011). http:\/\/www.molvis.org\/molvis\/v17\/a194. Accessed 23 June 2024."},{"key":"1987_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCONREL.2025.113753","author":"A-K Minnaert","year":"2025","unstructured":"Minnaert A-K, Nguyen V-P, Harizaj A, Goemaere I, Van Puyvelde B, Dhaenens M, et al. Collagenase-modified polydopamine nanoparticles for safe and effective vitreolysis. J Control Release. 2025. https:\/\/doi.org\/10.1016\/J.JCONREL.2025.113753.","journal-title":"J Control Release"},{"key":"1987_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113849","author":"K De Clerck","year":"2025","unstructured":"De Clerck K, De Smedt S, Remaut K, Peynshaert K. Toward successful retinal drug delivery after intravitreal injection: current strategies to overcome the inner limiting membrane. J Control Release. 2025. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113849.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01987-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:41:00Z","timestamp":1779108060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01987-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1987"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01987-6","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}